GTG 12.1% 9.3¢ genetic technologies limited

Ann: New Product Announcement, page-127

  1. 20,449 Posts.
    lightbulb Created with Sketch. 268

    once they sign a distribution deal would expect a massive rerate, from lastest announcement expected in coming months:

    Commercialisation and Product Distribution Plans:

    GTG intends to introduce the new ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’genetic tests to healthcare providers through a global network of distribution partners. The Company hasalready announced it is working with TGen in the United States and also Chinese partners connected to theHainan Free-Trade Zone. More announcements are anticipated in this regard in coming months as GTG movesto commercialise its suite of world-leading genetic tests.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
0.010(12.1%)
Mkt cap ! $12.29M
Open High Low Value Volume
8.7¢ 9.3¢ 8.0¢ $1.967K 23.02K

Buyers (Bids)

No. Vol. Price($)
2 46500 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 76366 1
View Market Depth
Last trade - 15.28pm 25/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.